Ovid Therapeutics Inc.
Records under this name other than the patents Ovid Therapeutics Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 47 patents it holds.
Showing 1 to 5 of 5 · Back to Ovid Therapeutics Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,395,817 | Methods and Compositions for Treatment of Epileptic Disorders Lapsed on the fee record Ended Jul 26, 2026 · Low confidence | Lapsed on the fee record | Ended Jul 26, 2026 | Low confidence |
| US 11,291,658 | Use of gaboxadol in the treatment of diabetes and related conditions Lapsed on the fee record Ended Apr 5, 2026 · USPTO record | Lapsed on the fee record | Ended Apr 5, 2026 | USPTO record |
| US 9,913,833 | Methods of treating developmental disorders using pipradrol Lapsed on the fee record Ended Mar 13, 2026 · USPTO record | Lapsed on the fee record | Ended Mar 13, 2026 | USPTO record |
| US 10,813,918 | Use of Gaboxadol in the treatment of diabetes and related conditions Lapsed on the fee record Ended Oct 27, 2024 · USPTO record | Lapsed on the fee record | Ended Oct 27, 2024 | USPTO record |
| US 9,351,968 | Methods of treating developmental disorders using pipradrol Lapsed on the fee record Ended May 31, 2024 · USPTO record | Lapsed on the fee record | Ended May 31, 2024 | USPTO record |